BioNexus Gene Lab Corp. Paid-in-Kind Interest
BioNexus Gene Lab Corp. (BGLC) reported Paid-in-Kind Interest of $6.79 thousand for the 9-month period ending 2023-09-30, per its 10-Q/A filed 2024-03-26.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2024-03-26
- BioNexus Gene Lab Corp. paid-in-kind interest for the quarter ending 2023-09-30 was $2.58K, a 48.73% increase year-over-year.
- BioNexus Gene Lab Corp. paid-in-kind interest for the quarter ending 2022-09-30 was $1.74K.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month |
|---|---|---|---|
| 2023-09-30 | $2.58K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-03-26 | $6.79K 10-Q/A · filed 2024-03-26 | |
| 2023-06-30 | $4.21K 10-Q · filed 2023-08-16 | ||
| 2022-09-30 | $1.74K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-03-26 | $5.52K 10-Q/A · filed 2024-03-26 | |
| 2022-06-30 | $3.79K 10-Q · filed 2023-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |